Manhattan Scientifics, Inc. (MHTX)
0.0000
0.00 (0.00%)
USD |
OTCM |
Sep 01, 16:00
Manhattan Scientifics Cash from Operations (Annual)
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.19M |
| December 31, 2022 | -0.349M |
| December 31, 2021 | -0.421M |
| December 31, 2020 | -0.388M |
| December 31, 2019 | -0.316M |
| December 31, 2018 | -0.682M |
| December 31, 2017 | -0.791M |
| December 31, 2016 | -4.559M |
| December 31, 2015 | 3.415M |
| December 31, 2014 | -2.535M |
| December 31, 2013 | -0.964M |
| December 31, 2012 | -1.078M |
| December 31, 2011 | -1.196M |
| Date | Value |
|---|---|
| December 31, 2010 | 0.462M |
| December 31, 2009 | -0.406M |
| December 31, 2008 | -0.70M |
| December 31, 2007 | -0.537M |
| December 31, 2006 | -0.331M |
| December 31, 2005 | -0.751M |
| December 31, 2004 | -0.445M |
| December 31, 2003 | -0.251M |
| December 31, 2002 | -0.934M |
| December 31, 2001 | -2.373M |
| December 31, 2000 | -3.994M |
| December 31, 1999 | -1.491M |
| December 31, 1998 | -1.224M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Tenax Therapeutics, Inc. | -35.80M |
| Exicure, Inc. | -8.555M |
| Century Therapeutics, Inc. | -103.88M |
| Absci Corp. | -92.92M |
| Celularity, Inc. | -13.25M |